BioInvent International AB (publ) Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
BioInvent International AB (publ) Stock Forecast and Price Target
According to esteemed experts, the average price target for BioInvent International AB (publ) to reach this year is kr83.00, with a potential upside of approximately 219.23%. This prediction is based on a high estimate of kr83.00 and a low estimate of kr83.00. If you want to buy BINV stock, it might be a good idea to look at its competitors too.
219.23% Upside
BioInvent International AB (publ) Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, BioInvent International AB (publ)'s Price has seen an increase, rising from kr0.00 to kr0.00. This represents a growth of 100.00%. Analysts predict that BioInvent International AB (publ)'s Fair Value will increase in the upcoming year, reaching kr27.62. This would represent an increase of 100.00%. Over the next seven years, experts predict that BioInvent International AB (publ)'s Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SOBI Stock Forecast | Swedish Orphan Biovitrum AB (p... | Outperform |
16
|
kr285.40 | Buy/Sell | kr293.00 | 13.88% |
| VITR Stock Forecast | Vitrolife AB (publ) | Buy |
18
|
kr166.30 | Buy/Sell | kr250.00 | 32.29% |
| BIOA B Stock Forecast | BioArctic AB (publ) | Outperform |
10
|
kr195.00 | Buy/Sell | kr372.40 | 79.49% |
| KARO Stock Forecast | Karo Healthcare AB | - |
12
|
kr60.70 | Buy/Sell | kr40.00 | -100.00% |
| GENO Stock Forecast | Genovis AB (publ.) | Outperform |
16
|
kr27.85 | Buy/Sell | kr75.67 | 81.33% |
BioInvent International AB (publ) Revenue Forecast for 2023 - 2025 - 2030
In the last three years, BioInvent International AB (publ)'s Revenue has seen a drop from kr147.37M to kr71.46M – a 51.51% decrease. Analysts predict that BioInvent International AB (publ)'s Revenue will increase in the upcoming year, reaching kr291.26M. This would represent an increase of 307.58%. Over the next seven years, experts predict that BioInvent International AB (publ)'s Revenue will grow at a rate of 853.52%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VICO Stock Forecast | Vicore Pharma Holding AB (publ... | Buy |
4
|
kr18.06 | Buy/Sell | kr70.75 | 259.91% |
| HNSA Stock Forecast | Hansa Biopharma AB (publ) | Buy |
6
|
kr28.94 | Buy/Sell | kr123.00 | 224.81% |
| XSPRAY Stock Forecast | Xspray Pharma AB (publ) | Outperform |
6
|
kr40.50 | Buy/Sell | kr120.00 | 164.20% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IMMNOV Stock Forecast | Immunovia AB (publ) | - |
0
|
kr1.94 | Buy/Sell | kr0.00 | -100.00% |
| ATORX Stock Forecast | Alligator Bioscience AB (publ) | Outperform |
0
|
kr0.90 | Buy/Sell | kr1.83 | 155.56% |
| CANTA Stock Forecast | Cantargia AB (publ) | Buy |
5
|
kr3.34 | Buy/Sell | kr13.67 | 289.22% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| XBRANE Stock Forecast | Xbrane Biopharma AB (publ) | Outperform |
5
|
kr0.22 | Buy/Sell | kr116.00 | 186.36% |
| IMMU Stock Forecast | Mendus AB (publ) |
9
|
kr0.45 | Buy/Sell | kr1.70 | 300.00% | |
| ACE Stock Forecast | Ascelia Pharma AB (publ) |
0
|
kr10.58 | Buy/Sell | kr19.50 | -7.84% |
BioInvent International AB (publ) EBITDA Forecast for 2023 - 2025 - 2030
BioInvent International AB (publ)'s EBITDA has grown in the last three years, jumping from kr-68.86M to kr-361.29M – an increase of 424.67%. In the following year, 2 experts forecast that BioInvent International AB (publ)'s EBITDA will decrease by 10.46%, to kr-323.50M. In 2030, professionals predict that BioInvent International AB (publ)'s EBITDA will decrease by 289.60%, to kr684.99M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| KDEV Stock Forecast | Karolinska Development AB (pub... |
8
|
kr1.57 | Buy/Sell | kr4.70 | 157.96% | |
| ISR Stock Forecast | ISR Immune System Regulation H... | - |
0
|
kr7.43 | Buy/Sell | kr0.00 | -100.00% |
| HAMLET B Stock Forecast | Hamlet BioPharma AB (publ) | - |
0
|
kr2.47 | Buy/Sell | kr0.00 | -100.00% |
BioInvent International AB (publ) EBIT Forecast for 2023 - 2025 - 2030
In the last three years, BioInvent International AB (publ)'s EBIT has increased by 394.34%, going from kr-74.96M to kr-370.56M. 2 analysts predict BioInvent International AB (publ)'s EBIT will decrease by 12.66% in the next year, reaching kr-323.63M. By 2030, professionals predict that BioInvent International AB (publ)'s EBIT will decrease by 285.23%, to kr686.37M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ONCO Stock Forecast | Oncopeptides AB (publ) |
0
|
kr2.91 | Buy/Sell | kr6.90 | 119.93% | |
| GUARD Stock Forecast | Guard Therapeutics Internation... |
8
|
kr29.20 | Buy/Sell | kr0.23 | 122.60% | |
| IVACC Stock Forecast | Intervacc AB (publ) |
10
|
kr4.21 | Buy/Sell | kr27.00 | 90.02% |
BioInvent International AB (publ) EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, BioInvent International AB (publ)'s EPS has seen an increase, rising from kr-2.66 to kr0.00. This represents a growth of 100.00%. Analysts predict that BioInvent International AB (publ)'s EPS will increase in the upcoming year, reaching kr-3.93. This would represent an increase of 100.00%. Over the next seven years, experts predict that BioInvent International AB (publ)'s EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SYNACT Stock Forecast | SynAct Pharma AB | - |
7
|
kr6.84 | Buy/Sell | kr15.00 | -100.00% |
| NICA Stock Forecast | Nanologica AB (publ) |
0
|
kr5.70 | Buy/Sell | kr14.75 | 92.98% | |
| CLBIO Stock Forecast | Corline Biomedical AB |
6
|
kr10.55 | Buy/Sell | kr35.00 | 203.32% |
Site Navigation
.jpg)